Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2009-04-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm8015409PMID 19402664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transmembrane Segment 6 of the Glut1 Glucose Transporter Is an Outer Helix and Contains Amino Acid Side Chains Essential for Transport Activity*

  2008cited by this paper
• Prodrug Approaches for CNS Delivery

  2008cited by this paper
• Large neutral amino acid transporter enables brain drug delivery via prodrugs.

  2008cited by this paper
• Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction

  2007cited by this paper
• Quench-flow analysis reveals multiple phases of GluT1-mediated sugar transport.

  2005cited by this paper
• Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

  2005cited by this paper
• Medicinal chemical properties of successful central nervous system drugs

  2005cited by this paper
• ABC transporters and the blood-brain barrier.

  2004cited by this paper
• Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1.

  2003cited by this paper
• Glycosyl Derivatives of Dopamine and l-dopa as Anti-Parkinson Prodrugs: Synthesis, Pharmacological Activity and In Vitro Stability Studies

  2003cited by this paper
• Blood-brain barrier drug targeting: the future of brain drug development.

  2003cited by this paper
• Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents.

  2000cited by this paper
• Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents.

  2000cited by this paper
• Experimental methods for studying drug uptake in the head and brain.

  2000cited by this paper
• The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.

  2000cited by this paper
• Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.

  2000cited by this paper
• The cell biology of the blood-brain barrier.

  1999cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999cited by this paper
• The Blood‐brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System

  1996cited by this paper
• Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter.

  1996cited by this paper
• Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study.

  1991cited by this paper
• Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

  1990cited by this paper
• The structure and function of the blood-brain barrier.

  1984cited by this paper
• TRANSPORT OF METABOLIC SUBSTRATES THROUGH THE BLOOD‐BRAIN BARRIER 1

  1977cited by this paper

• Development of Brain Permeable Drugs and Novel Strategies to Overcome the Brain Barriers for Treatment Purposes.

  2025cites this paper
• Prodrugs and their activation mechanisms for brain drug delivery

  2025cites this paper
• Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis

  2025cites this paper
• Targeting GLUT1 degradation with assembling glycopeptide for cancer inhibition

  2024cites this paper
• Galacturonic acid-capsaicin prodrug for prolonged nociceptive-selective nerve blockade.

  2024cites this paper
• High efficient synthesis of benzyl lactate through waste PLA alcoholysis by protic ionic salt

  2024cites this paper
• Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies.

  2023cites this paper
• Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges

  2022cites this paper
• Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)

  2022cites this paper
• Glycosylation and its research progress in endometrial cancer

  2022cites this paper
• Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics

  2022cites this paper
• Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

  2022cites this paper
• Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?

  2022cites this paper
• Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter

  2022cites this paper
• Active and Facilitated Transport in Drug Absorption

  2021cites this paper
• Systemic inflammation induced changes in protein expression of ABC transporters and ionotropic glutamate receptor subunit 1 in the cerebral cortex of familial Alzheimer`s disease mouse model.

  2021cites this paper
• Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.

  2021cites this paper
• Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration

  2021cites this paper
• Current Research on Pro-Drug Therapies for Parkinson's and Alzheimer's Disease.

  2021cites this paper
• Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates.

  2020cites this paper
• Curcumin Oligosaccharides (Gluco-oligosaccharides) Penetrate the Blood-Brain Barrier in Mouse Brain: Glycoside (Polysaccharide) Modification Approach for Brain Drug Delivery Across the Blood-Brain Barrier and Tumor Drug Delivery

  2020cites this paper
• Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells

  2020cites this paper
• The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics

  2020cites this paper
• Addressing the Biochemical Foundations of a Glucose-Based “Trojan Horse”-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment

  2020cites this paper
• Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

  2020cites this paper
• Probing the interaction between EC1-EC2 domain of E-cadherin with conformational structure of cyclic ADTC7 (Ac-CDTPDC-NH2) peptide using molecular docking approach

  2020cites this paper
• Recent progress in blood-brain barrier transportation research

  2019cites this paper
• Improving cellular uptake of therapeutic entities through interaction with components of cell membrane

  2019cites this paper
• A thermo-sensitive, injectable and biodegradable in situ hydrogel as a potential formulation for uveitis treatment

  2019cites this paper
• Developments in Carbohydrate-Based Cancer Therapeutics

  2019cites this paper
• Microwave-assisted synthesis and in vitro stability of N-benzylamide non-steroidal anti-inflammatory drug conjugates for CNS delivery.

  2019cites this paper
• Drug delivery to the brain

  2019cites this paper
• Chemoselective ester/ether C–O cleavage of methyl anisates by aluminum triiodide

  2018cites this paper
• Fine-tuning the physicochemical properties of peptide-based blood-brain barrier shuttles.

  2018cites this paper
• Chemical synthesis of an indomethacin ester prodrug and its metabolic activation by human carboxylesterase 1.

  2018cites this paper
• Design, Synthesis, and Blood-Brain Barrier Transport Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors.

  2018cites this paper
• Amino Acids in the Development of Prodrugs

  2018cites this paper
• Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties in vitro and in vivo

  2018cites this paper
• Application of Mono‐ and Disaccharides in Drug Targeting and Efficacy

  2018cites this paper
• Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease

  2017cites this paper
• Construction of biomimetic long-circulation delivery platform encapsulated by zwitterionic polymers for enhanced penetration of blood–brain barrier

  2017cites this paper
• The Route of Nanomaterials Entering Brain

  2017cites this paper
• Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.

  2017cites this paper
• Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery

  2017cites this paper
• Pyrilamine‐sensitive proton‐coupled organic cation (H+/OC) antiporter for brain‐specific drug delivery

  2017cites this paper
• Medicinal Chemistry and Brain Drug Penetrance

  2017cites this paper
• Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug

  2016influential citation
• A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells.

  2016cites this paper
• Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.

  2016cites this paper
• SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin

  2016cites this paper
• Membrane Transporters in Physiological Barriers of Pharmacological Importance.

  2016cites this paper
• Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier.

  2016cites this paper
• Delivery And Efficacy Of CDK4/6 Inhibitors In The Treatment Of Brain Tumors

  2016cites this paper
• Pathways for Drug Delivery to the Central Nervous System

  2016cites this paper
• Blood-Brain Barrier Methods

  2016cites this paper
• Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo.

  2016cites this paper
• Focused Ultrasound Mediated Blood-Brain Barrier Opening in Non-Human Primates: Safety, Efficacy and Drug Delivery

  2015cites this paper
• Quantitative and dynamic analysis of the focused-ultrasound induced blood-brain barrier opening in vivo for drug delivery

  2015cites this paper
• Synthesis of prodigiosene–estrogen conjugates: optimization of protecting group strategies and anticancer properties

  2015cites this paper
• Sugar conjugates of 3-hydroxy-4-pyridinones : synthesis and investigations into their potential for drug delivery to the brain

  2015influential citation
• Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood–brain barrier

  2015cites this paper
• Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.

  2015cites this paper
• Intriguing possibilities and beneficial aspects of transporter-conscious drug design.

  2015cites this paper
• Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions

  2015cites this paper
• Chapter 28 – Designing Prodrugs and Bioprecursors

  2015cites this paper
• Non-cell-based in vitro methods in the study of prodrug absorption and metabolism

  2015cites this paper
• Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.

  2015cites this paper
• Prodrug strategies for brain delivery

  2015cites this paper
• In Vivo Studies of Brain Exposure in Drug Discovery

  2015cites this paper
• Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes.

  2014cites this paper
• Novel Central Nervous System Drug Delivery Systems

  2014cites this paper
• Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier

  2014cites this paper
• Targeting Clinically Viable Protein-Protein Interactions via Rationally Designed Small Molecule Inhibitors

  2014cites this paper
• Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.

  2014cites this paper
• Design, Synthesis and Brain Uptake of LAT1-Targeted Amino Acid Prodrugs of Dopamine

  2013cites this paper
• In vitro cell models in predicting blood-brain barrier permeability of drugs

  2013cites this paper
• CNS drug targeting: have we travelled in right path?

  2013cites this paper
• LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.

  2013cites this paper
• The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so.

  2013cites this paper
• Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology.

  2013cites this paper
• Rational Approaches to Improving Selectivity in Drug Design

  2012cites this paper
• Designing prodrugs for the treatment of Parkinson's disease

  2012cites this paper
• Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.

  2012cites this paper
• Evidence-based approach to assess passive diffusion and carrier-mediated drug transport.

  2012cites this paper
• A focus on glucose-mediated drug delivery to the central nervous system.

  2012cites this paper
• Perspectives on brain-targeting drug delivery systems.

  2012cites this paper
• Permeability: Blood–Brain Barrier

  2012cites this paper
• Molecular structure and drug transport of the blood-brain barrier

  2012cites this paper
• Schleuservermittelter Transport von Wirkstoffen ins Gehirn

  2011cites this paper
• Targeting the neurovascular unit for treatment of neurological disorders.

  2011cites this paper
• Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen.

  2011cites this paper
• Shuttle-mediated drug delivery to the brain.

  2011cites this paper
• Prodrug Approaches for Central Nervous System Delivery

  2011cites this paper
• Drug Targeting to the Central Nervous System

  2011cites this paper
• Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene Delivery

  2011cites this paper
• D-galactose as a vector for prodrug design.

  2011cites this paper
• Prodrugs and endogenous transporters: are they suitable tools for drug targeting into the central nervous system?

  2011cites this paper
• Nanostructures for drug delivery to the brain.

  2011cites this paper
• Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.

  2011cites this paper
• Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery

  2011cites this paper